Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccine

References

• Durbin WJ. Pneumococcal infections. Pediatr Rev 2004;25: 418–24.
   PubMed Web of Science ®Google Scholar
• Myers C, Gervaix A. Streptococcus pneumoniae bacteraemia in children. Int J Antimicrob Agents 2007;30(Suppl 1): S24–8.
   PubMedGoogle Scholar
• Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, Rumke HC, . Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 2004;363:1871–2.
   PubMed Web of Science ®Google Scholar
• Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, . Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 2007;196:1346–54.
   PubMed Web of Science ®Google Scholar
• Harwell JI, Brown RB. The drug-resistant pneumococcus: clinical relevance, therapy, and prevention [see comment]. Chest 2000;117:530–41.
   PubMed Web of Science ®Google Scholar
• Tuomanen EI, Austrian R, Masure HR. Pathogenesis of pneumococcal infection. N Engl J Med 1995;332:1280–4.
   PubMed Web of Science ®Google Scholar
• Williams C, Masterton R. Pneumococcal immunisation in the 21st century. J Infect 2008;56:13–9.
   PubMed Web of Science ®Google Scholar
• Sleeman KL, Griffiths D, Shackley F, Diggle L, Gupta S, Maiden MC, . Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006;194:682–8.
   PubMed Web of Science ®Google Scholar
• Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H, . Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008;26:3277–81.
   PubMed Web of Science ®Google Scholar
• Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, . Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008;197:1016–27.
   PubMed Web of Science ®Google Scholar
• Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, . Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case–control study. Lancet 2006;368:1495–502.
   PubMed Web of Science ®Google Scholar
• Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006. Euro Surveill 2008;13(35). pii: 18962.
   PubMedGoogle Scholar
• Hanage WP, Huang SS, Lipsitch M, Bishop CJ, Godoy D, Pelton SI, . Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 2007;195:347–52.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests. Wayne, PA: CLSI; 2006. 37s.
   Google Scholar
• Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, PA: CLSI; 2006. 49s.
   Google Scholar
• THL Tilastotietokanta; THL Statistisk databas; THL Statistical database. Finland: National Public Health Institute; 2009. Available at: http://www3.ktl.fi/ (accessed 12 April 2009).
   Google Scholar
• Klemets P, Lyytikainen O, Ruutu P, Kaijalainen T, Leinonen M, Ollgren J, . Trends and geographical variation in invasive pneumococcal infections in Finland. Scand J Infect Dis 2008;40:621–8.
   PubMed Web of Science ®Google Scholar
• Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, . Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998;102:1087–97.
   PubMed Web of Science ®Google Scholar
• FiRe-Finnish Study Group for Antimicrobial Resistance. Streptococcus pneumoniae; antimicrobial resistance. Finland: National Institute for Health and Welfare; 2009. Available at: http://www.ktl.fi/portal/english/projects/fire/finres/finres__antimicrobial_resistance_statistics_/streptococcus_pneumoniae/ (accessed 12 April 2009).
   Google Scholar
• Grivea IN, Panagiotou M, Tsantouli AG, Syrogiannopoulos GA. Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among day-care center attendees in central Greece. Pediatr Infect Dis J 2008;27:519–25.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Deeks SL, Zulz T, Bruden D, Navarro C, Lovgren M, . International Circumpolar Surveillance System for invasive pneumococcal disease, 1999–2005. Emerg Infect Dis 2008;14:25–33.
   PubMed Web of Science ®Google Scholar
• Tsai CJ, Griffin MR, Pekka Nuorti J, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008;46:1664–72.
   PubMed Web of Science ®Google Scholar
• Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, . Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis 2004;190:2031–8.
   PubMed Web of Science ®Google Scholar
• O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, . Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J Infect Dis 2007;196:1211–20.
   PubMed Web of Science ®Google Scholar
• Vestrheim DF, Hoiby EA, Bergsaker MR, Ronning K, Aaberge IS, Caugant DA. Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine 2010; 28:2214–21.
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, . Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006;354:1455–63.
   PubMed Web of Science ®Google Scholar
• De Carvalho Gomes H, Muscat M, Monnet DL, Giesecke J, Lopalco PL. Use of seven-valent pneumococcal conjugate vaccine (PCV7) in Europe, 2001–2007. Euro Surveill 2009; 14. pii: 19159.
   Google Scholar